{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:51:44Z","timestamp":1791571904323,"version":"4.3.4"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,6]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Dermatofibrosarcoma protuberans (DFSP) is a malignant skin tumor originated from of fibroblast, which remains a challenge in terms of diagnosis and treatment, especially in those with locally-advanced disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>Case 1 is a 38-year-old male complained with a mass at his left temporal and left mandibular region, and invaded his left orbital region. Case 2 is a 54-year-old male with a mass located in this chest region. The tumor invaded 2th and 3rd ribs with suspicious intra-thoracic invasion. Case 3 is a 63-year-old male with a recurrent tumor in abdominal wall which invaded peritoneum of abdominal wall. Case 4 is a 11-year-old boy with a mass located in his left forearm, which invaded the abductor pollicis longus, extensor pollicis brevis, and extensor carpi radialis longus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>These 4 patients were diagnosed with DFSP with local invasion. Case 3 was pathologically diagnosed with reginal fibrosarcomatous transformation (FS-DFSP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Case 1 received imatinib 400\u2009mg\/day as neo-adjuvant therapy. After 6 months, the mass significantly shrunk and Mohs surgical resection and reconstruction with free anterolateral thigh flap were performed. Case 2 received Mohs surgical resection and reconstruction with contralateral pedicled latissimus dorsi flap. Case 3 and Case 4 also received Mohs surgical resection of the tumor and construction with a free anterolateral thigh flap.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>All of the 4 patients achieved clean margins by frozen section during surgery. At the last follow-up, none of them experienced disease recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>Mohs micrographic surgery is an effective surgical technique for locally-advanced DFSP patients. Imatinib neo-adjuvant therapy is an option when surgical resection with negative margin may cause unacceptable functional or cosmetic outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000047778","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T08:01:38Z","timestamp":1773043298000},"page":"e47778","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Management of locally-advanced dermatofibrosarcoma protuberans: Four cases report"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5346-8828","authenticated-orcid":false,"given":"Haoran","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Burn and Plastic Surgery, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaisheng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Burn and Plastic Surgery, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261009","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jaad.2024.05.088","article-title":"The epidemiology of dermatofibrosarcoma protuberans incidence, metastasis, and death among various population groups: a SEER database analysis.","volume":"91","author":"Maghfour","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"R2-20261009","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.det.2019.05.006","article-title":"Dermatofibrosarcoma protuberans.","volume":"37","author":"Aubrey","year":"2019","journal-title":"Dermatol Clin"},{"key":"R3-20261009","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s12094-006-0067-z","article-title":"Dermatofibrosarcoma protuberans: review of 20-years experience.","volume":"8","author":"Ruiz-Tovar","year":"2006","journal-title":"Clin Transl Oncol"},{"key":"R4-20261009","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.anndiagpath.2016.09.013","article-title":"Dermatofibrosarcoma protuberans: pathology, genetics, and potential therapeutic strategies.","volume":"25","author":"Thway","year":"2016","journal-title":"Ann Diagn Pathol"},{"key":"R5-20261009","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00000637-199703000-00010","article-title":"Dermatofibrosarcoma protuberans (DFSP): growth characteristics based on tumor modeling and a review of cases treated with Mohs micrographic surgery.","volume":"38","author":"Haycox","year":"1997","journal-title":"Ann Plast Surg"},{"key":"R6-20261009","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0190-9622(97)70179-8","article-title":"Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans.","volume":"37","author":"Ratner","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"R7-20261009","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0960-7404(00)00034-7","article-title":"Dermatofibrosarcoma protuberans: what is the best surgical approach?","volume":"8","author":"Sondak","year":"1999","journal-title":"Surg Oncol"},{"key":"R8-20261009","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/j.1365-2133.2005.06823.x","article-title":"Clinical variants of the preprotuberant stage of dermatofibrosarcoma protuberans.","volume":"153","author":"Martin","year":"2005","journal-title":"Br J Dermatol"},{"key":"R9-20261009","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.suc.2016.05.006","article-title":"Dermatofibrosarcoma protuberans.","volume":"96","author":"Reha","year":"2016","journal-title":"Surg Clin North Am"},{"key":"R10-20261009","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jaad.2006.09.006","article-title":"Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002.","volume":"56","author":"Criscione","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R11-20261009","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3892\/ol.2015.3966","article-title":"Clinicopathological features of dermatofibrosarcoma protuberans.","volume":"11","author":"Larbcharoensub","year":"2016","journal-title":"Oncol Lett"},{"key":"R12-20261009","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/1097-0142(196207\/08)15:4<717::AID-CNCR2820150405>3.0.CO;2-2","article-title":"Dermatofibrosarcoma protuberans.A study of 115 cases.","volume":"15","author":"Taylor","year":"1962","journal-title":"Cancer"},{"key":"R13-20261009","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/ejso.1999.0663","article-title":"Revision surgery in dermatofibrosarcoma protuberans of the trunk and extremities.","volume":"25","author":"Lindner","year":"1999","journal-title":"Eur J Surg Oncol"},{"key":"R14-20261009","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1001\/archdermatol.2012.1440","article-title":"Efficacy of Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans: systematic review.","volume":"148","author":"Foroozan","year":"2012","journal-title":"Arch Dermatol"},{"key":"R15-20261009","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.soc.2016.05.011","article-title":"Dermatofibrosarcoma protuberans: wide local excision versus mohs micrographic surgery.","volume":"25","author":"Mullen","year":"2016","journal-title":"Surg Oncol Clin N Am"},{"key":"R16-20261009","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/iwj.12157","article-title":"Artificial dermis (Matriderm\u00ae) followed by skin graft as an option in dermatofibrosarcoma protuberans with complete circumferential and peripheral deep margin assessment.","volume":"12","author":"Bertolli","year":"2015","journal-title":"Int Wound J"},{"key":"R17-20261009","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2478\/abm-2023-0060","article-title":"Fibrosarcomatous dermatofibrosarcoma protuberans: a rapidly growing 30\u2009cm mass on the posterior scalp.","volume":"17","author":"Lerttiendamrong","year":"2023","journal-title":"Asian Biomed (Res Rev News)"},{"key":"R18-20261009","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s40064-015-1125-1","article-title":"Recurrent abdominal wall dermatofibrosarcoma protuberans in a child: a challenging reconstruction.","volume":"4","author":"Vallam","year":"2015","journal-title":"Springerplus"},{"key":"R19-20261009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/gcc.10202","article-title":"Genetics of dermatofibrosarcoma protuberans family of tumors: From ring chromosomes to tyrosine kinase inhibitor treatment.","volume":"37","author":"Sirvent","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"R20-20261009","doi-asserted-by":"crossref","first-page":"8478","DOI":"10.18632\/oncotarget.23899","article-title":"EGFR is involved in dermatofibrosarcoma protuberans progression to high grade sarcoma.","volume":"9","author":"Osio","year":"2018","journal-title":"Oncotarget"},{"key":"R21-20261009","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/(SICI)1098-2264(199811)23:3<263::AID-GCC9>3.0.CO;2-#","article-title":"COL1A1-PDGFB fusion in a ring chromosome 4 found in a dermatofibrosarcoma protuberans.","volume":"23","author":"Navarro","year":"1998","journal-title":"Genes Chromosomes Cancer"},{"key":"R22-20261009","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1080\/14737140.2017.1390431","article-title":"Dermatofibrosarcoma protuberans and gastrointestinal stromal tumor as models for targeted therapy in soft tissue sarcomas.","volume":"17","author":"Kose\u0142a-Paterczyk","year":"2017","journal-title":"Expert Rev Anticancer Ther"},{"key":"R23-20261009","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.2169\/internalmedicine.55.6836","article-title":"Effectiveness of imatinib mesylate treatment in a patient with dermatofibrosarcoma protuberans with pulmonary and pancreatic metastases.","volume":"55","author":"Tatai","year":"2016","journal-title":"Intern Med"},{"key":"R24-20261009","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1468-3083.2010.03774.x","article-title":"Treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without surgical resection.","volume":"25","author":"Rutkowski","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R25-20261009","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1158\/1078-0432.CCR-09-3401","article-title":"Imatinib mesylate as a preoperative therapy in dermatofibrosarcoma: results of a multicenter phase II study on 25 patients.","volume":"16","author":"K\u00e9rob","year":"2010","journal-title":"Clin Cancer Res"},{"key":"R26-20261009","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1200\/JCO.2009.25.7899","article-title":"Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials.","volume":"28","author":"Rutkowski","year":"2010","journal-title":"J Clin Oncol"},{"key":"R27-20261009","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/jamadermatol.2018.4940","article-title":"Imatinib treatment for locally advanced or metastatic dermatofibrosarcoma protuberans: a systematic review.","volume":"155","author":"Navarrete-Dechent","year":"2019","journal-title":"JAMA Dermatol"},{"key":"R28-20261009","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1158\/1078-0432.CCR-15-1243","article-title":"Efficacy and biological activity of imatinib in metastatic dermatofibrosarcoma protuberans (DFSP).","volume":"22","author":"Stacchiotti","year":"2016","journal-title":"Clin Cancer Res"},{"key":"R29-20261009","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00000478-199805000-00009","article-title":"Fibrosarcomatous (\u201cHigh-Grade\u201d) dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance.","volume":"22","author":"Mentzel","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"R30-20261009","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1002\/1097-0142(20000615)88:12<2711::AID-CNCR9>3.0.CO;2-M","article-title":"Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution.","volume":"88","author":"Bowne","year":"2000","journal-title":"Cancer"},{"key":"R31-20261009","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/DAD.0b013e3182120671","article-title":"Dermatofibrosarcoma protuberans treated with wide local excision and followed at a cancer hospital: prognostic significance of clinicopathologic variables.","volume":"34","author":"Erdem","year":"2012","journal-title":"Am J Dermatopathol"},{"key":"R32-20261009","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jaad.2014.11.020","article-title":"Prognostic impact of fibrosarcomatous transformation in dermatofibrosarcoma protuberans: a cohort study.","volume":"72","author":"Hoesly","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"R33-20261009","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jaad.2014.03.018","article-title":"A systematic review of outcome data for dermatofibrosarcoma protuberans with and without fibrosarcomatous change.","volume":"71","author":"Liang","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"R34-20261009","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jid.2016.06.634","article-title":"Adaptive immunity in fibrosarcomatous dermatofibrosarcoma protuberans and response to imatinib treatment.","volume":"137","author":"Tazzari","year":"2017","journal-title":"J Invest Dermatol"},{"key":"R35-20261009","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ejso.2017.03.011","article-title":"Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate \u2013 the impact of fibrosarcomatous transformation.","volume":"43","author":"Rutkowski","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"R36-20261009","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ijrobp.2013.02.024","article-title":"Dermatofibrosarcoma protuberans: long-term outcomes of 53 patients treated with conservative surgery and radiation therapy.","volume":"86","author":"Castle","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R37-20261009","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.3390\/jcm13061798","article-title":"The role of postoperative radiotherapy in the management of dermatofibrosarcoma protuberans: a multidisciplinary systematic review.","volume":"13","author":"Fionda","year":"2024","journal-title":"J Clin Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000047778","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:08:29Z","timestamp":1791569309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000047778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047778","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"2025-09-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}